Inventor · disambiguated record
Valentina Goldfinger
Also filed as: GOLDFINGER VALENTINA
31 granted patents·4 pending applications·431 citations·filing 2016–2024
98Inventor score
Top patents by PatentIndex Score
35 records- 0199US11826409B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Nov 28, 2023·6 cites·20 claims
- 0299US11786584B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Oct 17, 2023·4 cites·20 claims
- 0399US11065315B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jul 20, 2021·12 cites·20 claims
- 0499US11058754B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jul 13, 2021·14 cites·24 claims
- 0599US10799569B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Oct 13, 2020·14 cites·17 claims
- 0699US10377802B2Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Aug 13, 2019·83 cites·20 claims
- 0799US10253077B2Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Apr 9, 2019·94 cites·16 claims
- 0898US10532091B1Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Jan 14, 2020·14 cites·20 claims
- 0998US10478480B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Nov 19, 2019·14 cites·20 claims
- 1098US10449238B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Oct 22, 2019·18 cites·20 claims
- 1197US10654904B2Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted May 19, 2020·20 cites·30 claims
- 1297US10597432B2Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Mar 24, 2020·17 cites·20 claims
- 1397US10500259B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersimmatics biotechnology GmbH·Filed 2017·Granted Dec 10, 2019·17 cites·20 claims
- 1497US10487126B2Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Nov 26, 2019·17 cites·20 claims
- 1597US10383930B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Aug 20, 2019·16 cites·16 claims
- 1697US10376568B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Aug 13, 2019·14 cites·20 claims
- 1797US10238727B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Mar 26, 2019·13 cites·20 claims
- 1897US10155032B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Dec 18, 2018·12 cites·13 claims
- 1997US9993539B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jun 12, 2018·13 cites·13 claims
- 2096US9908920B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersimmatics biotechnology GmbH·Filed 2016·Granted Mar 6, 2018·15 cites·22 claims
- 2193US2025074961A1Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 2291US2024016908A1Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 2390US10654903B2Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted May 19, 2020·2 cites·20 claims
- 2487US11111280B2Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Sep 7, 2021·1 cites·38 claims
- 2586US10597433B2Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Mar 24, 2020·1 cites·20 claims
- 2685US12180259B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Dec 31, 2024·0 cites·19 claims
- 2785US12144852B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Nov 19, 2024·0 cites·19 claims
- 2885US12102670B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Oct 1, 2024·0 cites·19 claims
- 2985US12097249B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Sep 24, 2024·0 cites·20 claims
- 3085US12076381B2Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Sep 3, 2024·0 cites·20 claims
- 3185US2022152175A1Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Application pending·0 cites
- 3284US12173043B2Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Dec 24, 2024·0 cites·20 claims
- 3381US11905319B2Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Feb 20, 2024·0 cites·20 claims
- 3476US10899806B2Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 26, 2021·0 cites·20 claims
- 3558US2023024554A1Method of characterizing the binding characteristics between a peptide of interest and mhc moleculesIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →